Standout Papers

Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3 2011 2026 2016 2021 580
  1. Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3 (2014)
    Stefan Zeuzem, Geoffrey Dusheiko et al. New England Journal of Medicine
  2. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial (2011)
    Evgeny Krupitsky, Edward V. Nunes et al. The Lancet

Immediate Impact

2 from Science/Nature 65 standout
Sub-graph 1 of 20

Citing Papers

Modular Construction of Multivariate Metal–Organic Frameworks for Luminescent Sensing
2025 Standout
Management of Depression in Adults
2024 Standout
2 intermediate papers

Works of Ari Illeperuma being referenced

Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
2014 Standout
Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial
2011 Standout

Author Peers

Author Last Decade Papers Cites
Ari Illeperuma 843 79 578 345 13 1.2k
Margaret MacDonald 808 38 412 291 31 1.0k
Ahmed T. Ahmed 663 64 545 156 33 1.3k
Paul K Nelson 925 50 719 154 11 1.3k
Calvin Lai 935 45 307 409 29 1.2k
Paolo Mezzelani 491 92 324 120 45 878
Liyun Ni 336 165 356 35 19 1.1k
Rajni Mehta 762 51 541 62 24 1.3k
Ngoc Wasson 633 45 601 45 23 1.1k
Edith Collins 247 92 112 250 22 1.2k
D. Purdie 581 27 452 145 15 1.3k

All Works

Loading papers...

Rankless by CCL
2026